| CCC | I452 |
NCI-H226 cell line is a well-established human non-small cell lung cancer (NSCLC) cell line that has been widely used in research focused on studying lung cancer biology, drug resistance mechanisms, and potential therapeutic interventions. The NCI-H226 cell line was derived from a malignant pleural effusion of a 44-year-old Caucasian male patient with squamous cell lung carcinoma and was established at the National Cancer Institute (NCI) in 1989.
NCI-H226 cells are commonly utilized in experimental models to investigate various aspects of lung cancer, including cell proliferation, migration, invasion, and response to anti-cancer drugs. The cell line retains key characteristics of squamous cell lung carcinoma, making it a valuable tool for studying the genetic and molecular alterations associated with this type of lung cancer.
Researchers use the NCI-H226 cell line to explore the underlying mechanisms of lung cancer progression, metastasis, and drug resistance, as well as to identify potential biomarkers and therapeutic targets for NSCLC. By studying NCI-H226 cells, scientists aim to uncover novel insights into the biology of squamous cell lung carcinoma and develop targeted therapies that can improve patient outcomes.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI452Hu11 | Human H226 Lung Squamous Carcinoma Cells (H226) | For research use only. It is not approved for human or animal use, or for applications in in vitro diganostic procedures. |
| Extracts | n/a | Extract of H226 Lung Squamous Carcinoma Cells (H226) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | n/a | Medium for H226 Lung Squamous Carcinoma Cells (H226) (If Necessary) | Cell Culture Medium Customized Service Offer |